Therefore, to examine whether membrane-expressed NCL is essential for regulating functions in cancer cells, we neutralized membrane-expressed NCL using monoclonal anti-NCL antibodies on MDA-MB-231 and HCT-116 cells and MCF-10A and CCD-18Co cells in vitro. The gene discussed is NUCLEOLIN; the disease is cancer.